Healthcare/BiotechAs of 2025-12-31
Julian Baker
Baker Brothers Advisors LP
Co-founder of Baker Bros. Advisors. Biotech-focused hedge fund managing $17 billion, known for long-term concentrated investments in drug development companies.
$17.01BAUM
75Holdings
2025-12-31 Summary
5개 종목 신규 매수 (TERN, JBIO, BCRX 등) · 6개 종목 추가 매수 (CTNM, TECX, CRNX 등) · 6개 비중 축소 · Top holding: INCY 17.8%
Portfolio Heatmap
Size = portfolio weight · Green = added · Red = reducedThis Quarter's Trades
2025-12-31 기준New Buy5
TERNTerns Pharmaceuticals, Inc.$38.38M0.2%
JBIOJade Biosciences, Inc.$25.32M0.1%
BCRXBioCryst Pharmaceuticals, Inc.$22.02M0.1%
CNTACentessa Pharmaceuticals plc$16.78M<0.1%
DYNDyne Therapeutics, Inc.$15.91M<0.1%
Holdings
75 positions| # | Stock ⇅ | Weight ↓ | Shares | Value | Change ⇅ | Trend |
|---|---|---|---|---|---|---|
| 1 |  CELCCelcuity Inc. | 10.36% | 7,915,792 | $789.52M | +0.00% | No Change |
| 2 |  RVMDRevolution Medicines, Inc. | 9.89% | 9,455,357 | $753.12M | +0.00% | No Change |
| 3 |  KYMRKymera Therapeutics, Inc. | 8.84% | 8,657,242 | $673.62M | +30.16% | Added |
| 4 |  SMMTSummit Therapeutics Inc. | 8.35% | 36,391,063 | $636.48M | +7.91% | Added |
| 5 |  RYTMRhythm Pharmaceuticals, Inc. | 7.87% | 5,604,483 | $599.90M | +0.00% | No Change |
| 6 |  KODKodiak Sciences Inc. | 7.31% | 19,919,186 | $556.94M | +15.07% | Added |
| 7 |  PRAXPraxis Precision Medicines, Inc. | 4.36% | 1,126,488 | $332.02M | +63.38% | Added |
| 8 |  ALKSAlkermes plc | 3.68% | 10,012,267 | $280.14M | +23.74% | Added |
| 9 |  GRALGRAIL, Inc. | 2.34% | 2,085,333 | $178.48M | +27.92% | Added |
| 10 |  EWTXEdgewise Therapeutics, Inc. | 2.14% | 6,575,940 | $163.18M | -9.99% | Partial Sell |
FAQ
Need Deeper Analysis?
Track Julian Baker's portfolio changes in real-time,
compare gurus head-to-head, and analyze performance vs S&P 500 with Premium.